← back to search

Yun Yen

American Cancer Society · TW
Area of research
Cancer Research · Inorganic Chemistry
Research interest
Research interests include Metal-Catalyzed Oxygenation Mechanisms, RNA modifications and cancer, Cancer, Hypoxia, and Metabolism, and Metal complexes synthesis and properties.
h-index
74
citations
22,814
works
674
NIH funding
primary concept
Medicine
email

Recent publications

Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer Cells upon dNTP Depletion
Cells 2021cited by 14position: middledoi
Enabling Technologies for Personalized and Precision Medicine
Trends in biotechnology 2020cited by 470position: middledoi
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
Annals of Oncology 2020cited by 238position: middledoi
CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing
Proceedings of the National Academy of Sciences 2016cited by 166position: middledoi
Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
Proceedings of the National Academy of Sciences 2014cited by 405position: lastdoi
Hepatobiliary Cancers, Version 2.2014
Journal of the National Comprehensive Cancer Network 2014cited by 129position: middledoi
Detection and Phenotyping of Circulating Tumor Cells in High-Risk Localized Prostate Cancer
Clinical Genitourinary Cancer 2014cited by 54position: middledoi
Bcl2 Induces DNA Replication Stress by Inhibiting Ribonucleotide Reductase
Cancer Research 2013cited by 46position: middledoi
Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth
Journal of Controlled Release 2012cited by 87position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark E. Davis · Centers for Disease Control and Prevention3 papers (2012–2016)Jonathan E. Zuckerman · University of California, Los Angeles3 papers (2012–2016)Joseph Chao · Amgen (United States)1 papers (2016–2016)Chih‐Ming Ho · Fu Jen Catholic University1 papers (2020–2020)William C. Mobley · University of California San Diego1 papers (2020–2020)Dong M. Shin · Emory Healthcare1 papers (2012–2012)Steven T. Rosen · City Of Hope National Medical Center1 papers (2020–2020)Dean Ho · National University of Singapore1 papers (2020–2020)Taofeek K. Owonikoko · New Mexico Cancer Center1 papers (2013–2013)Edward Kai‐Hua Chow · Creative Technologies (United States)1 papers (2020–2020)Ali Zarrinpar · Florida College1 papers (2020–2020)Andrew J. Clark · California Institute of Technology1 papers (2016–2016)Timothy G. Wilson · Huntsman Cancer Institute1 papers (2014–2014)James Lin · Rush University Medical Center1 papers (2016–2016)Walter J. Curran · Piedmont Atlanta Hospital1 papers (2013–2013)Mohammad Aminur Rahman · University of Southern Queensland1 papers (2012–2012)Robert J. Morgan · Mayo Clinic1 papers (2014–2014)Chung Hang Jonathan Choi · Chinese University of Hong Kong1 papers (2012–2012)Geoffrey S. Ginsburg · University of Alabama at Birmingham1 papers (2020–2020)Garry P. Nolan · Stanford University1 papers (2020–2020)